Merchant, Fahar

Insider profile

Performance

Overall performance
1.2

Performance over holding periods
1.2
30 days 90 days 120 days
Average return -16% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Merchant, Fahar's trades of Medicenna Therapeutics Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-02 2026-05-28 B Purchase
25,867
374.60
CA$1,778,030
25,867 374.60 CA$1,778,030
2026-06-02 2026-05-28 B Purchase
95,568 -7.4%
253.34
CA$1,243,520
95,568 -7.4% 253.34 CA$1,243,520
2025-12-15 2025-12-15 B Purchase
19,473 -27.7%
412.90
CA$2,020,753
19,473 -27.7% 412.90 CA$2,020,753
2025-12-12 2025-12-12 B Purchase
15,000 +48.4%
1.12
CA$16,800
15,000 +48.4% 1.12 CA$16,800
2023-02-22 2023-02-21 B Purchase
30,000 +0.6%
0.92
CA$27,600
30,000 +0.6% 0.92 CA$27,600